Simon G. Ammanuel

Simon G. Ammanuel

Auto-generated profile, based on publicly available information

Simon G. Ammanuel

Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2019 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
HHH. Haraldsson
H. Haraldsson
JLJoseph Leach
Joseph Leach
EKE.I. Kao
E.I. Kao
AWA.G. Wright
A.G. Wright
SAS.G. Ammanuel
S.G. Ammanuel
MAM.R. Amans
M.R. Amans
BACKGROUND AND PURPOSE: Idiopathic intracranial hypertension is commonly associated with transverse sinus stenosis, a venous cause of pulsatile tinnitus. In patients with idiopathic intracranial hypertension, CSF drainage via lumbar puncture decreases intracranial pressure, which relieves the stenosis, and may provide at least temporary cessation of pulsatile tinnitus. The objective of this study was to evaluate changes in venous blood flow caused by lowered intracranial pressure in patients with pulsatile tinnitus to help identify the cause of pulsatile tinnitus. MATERIALS AND METHODS: Ten patients with suspected transverse sinus stenosis as a venous etiology for pulsatile tinnitus symptoms underwent MR imaging before and after lumbar puncture in the same session. The protocol included flow assessment and rating of pulsatile tinnitus intensity before and after lumbar puncture and MR venography before lumbar puncture. Post-lumbar puncture MR venography was performed in 1 subject. RESULTS: There was a lumbar puncture–induced reduction in venous peak velocity that correlated with the opening pressure (r = −0.72, P = .019) without a concomitant reduction in flow rate. Patients with flow jets had their peak velocity reduced by 0.30 ± 0.18 m/s (P = .002), correlating with a reduction in CSF pressure (r = 0.82, P = .024) and the reduction in subjectively scored pulsatile tinnitus intensity (r = 0.78, P = .023). The post-lumbar puncture MR venography demonstrated alleviation of the stenosis. CONCLUSIONS: Our results show a lumbar puncture–induced reduction in venous peak velocity without a concomitant reduction in flow rate. We hypothesize that the reduction is caused by the expansion of the stenosis after lumbar puncture. Our results further show a correlation between the peak velocity and pulsatile tinnitus intensity, suggesting the flow jet to be instrumental in the development of sound.

30 July 2019 in bioRxiv
Verified
Preprint
Open access
BSBrennan Sullivan
Brennan Sullivan
SASimon Ammanuel
Simon Ammanuel
PKPavel Kipnis
Pavel Kipnis
YAYoichi Araki
Yoichi Araki
RHRichard L. Huganir
Richard L. Huganir
SKShilpa Kadam
Shilpa Kadam
Loss-of-function SYNGAP1 mutations cause a neurodevelopmental disorder characterized by intellectual disability and epilepsy. SYNGAP1 is a Ras-GTPase-activating protein that underlies the formation and experience-dependent regulation of postsynaptic densities. The mechanisms that contribute to this proposed monogenic cause of intellectual disability and epilepsy remain unresolved. Here, we establish the phenotype of the epileptogenesis in a Syngap1 +/- mouse model using 24h video electroencephalogram/electromyogram (vEEG/EMG) recordings at advancing ages. A progressive worsening of clinically-similar seizure phenotypes, interictal spike frequency, sleep dysfunction, and hyperactivity was identified in Syngap1 +/- mice. Interictal spikes emerged predominantly during NREM in 24h vEEG of Syngap1 +/- mice. Myoclonic seizures occurred at behavioral-state transitions both in Syngap1 +/- mice and during an overnight EEG from a child with SYNGAP1 haploinsufficiency. In Syngap1 +/- mice, EEG spectral power analyses identified a significant loss of cortical gamma homeostasis during behavioral-state transitions from NREM to Wake and NREM to REM. The loss of gamma homeostasis was associated with a region- and location-specific significant increase of GluA2 AMPA receptor subunit expression in the somas of parvalbumin-positive (PV+) interneurons. Acute dosing with Perampanel, an FDA approved AMPA antagonist significantly rescued cortical gamma homeostasis, identifying a novel mechanism implicating Ca 2+ impermeable AMPARs on PV+ interneurons underlying circuit dysfunction in SYNGAP1 haploinsufficiency.

15 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
BSBrennan Sullivan
Brennan Sullivan
PKPavel Kipnis
Pavel Kipnis
SASimon G. Ammanuel
Simon G. Ammanuel
SKShilpa Kadam
Shilpa Kadam
Objective: SYNGAP1 encephalopathy is a developmental and epileptic encephalopathy caused by pathogenic loss of function variants. Syngap1 -heterozygous (Het +/- ) mice demonstrate progressive epilepsy with multiple seizure phenotypes in adulthood. Here, we investigate early-life seizures in Het +/- pups and explore of Syngap1 encephalopathy during development. Methods: Post-natal day 7 (P7) and P12 mice were investigated by tethered video-electroencephalographic (vEEG). The effects of GABAergic drugs phenobarbital (PB) and pentylenetetrazol (PTZ) were investigated at P7 and P12, respectively. 24h tethered vEEG was performed at P24, and telemetric 24h vEEG with 6h sleep deprivation was performed at P35. The effect of perampanel (PMP), an AMPA receptor antagonist, was investigated at P24. Results: Het +/- mice have spontaneous early-life seizures that lack an overt behavioral phenotype. These subclinical seizures are refractory to PB, but the GABA A receptor (GABA A R) antagonist PTZ significantly reduced seizure frequency suggesting that GABAergic signaling may promote seizure generation in Het +/- pups. At juvenile ages, Het +/- pups recapitulated the early emergence of high gamma (35-50Hz) during NREM and disruption of behavioral-state gamma homeostasis. This biomarker was significantly exacerbated in Het +/- pups after increasing sleep pressure with sleep deprivation. Significance: Seizures during development have adverse effects on cognitive function. Therefore, an improved understanding of the SYNGAP1 epilepsy during developmental ages is necessary to delineate the deleterious interactions between aberrant synaptic function and recurrent seizures. The development of evidence-based therapies for early-life intervention will benefit from these insights.